GeoPharma, Inc. Announces the Acceptability of Their Largo Cephalosporin Plant

LARGO, Fla., March 2, 2010 (GLOBE NEWSWIRE) -- GeoPharma, Inc. (Nasdaq:GORX) (the "Company") announced today that the FDA Office of Compliance has completed the evaluation of its Largo, Florida manufacturing facility dedicated to the production of Cephalosporin antibiotics and has indicated, based on the adequacy of the Company's written response, that it is acceptable to manufacture upon FDA approval of its Cephalexin ANDA.